{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T10:09:07Z","timestamp":1769508547029,"version":"3.49.0"},"reference-count":124,"publisher":"Elsevier","isbn-type":[{"value":"9780443415845","type":"print"}],"license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010312"],"award-info":[{"award-number":["W81XWH2010312"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["W81XWH2010332"],"award-info":[{"award-number":["W81XWH2010332"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT94252310010"],"award-info":[{"award-number":["HT94252310010"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","award":["HT94252310613"],"award-info":[{"award-number":["HT94252310613"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000884","name":"Cancer Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001377","name":"Walther Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA280097"],"award-info":[{"award-number":["R01CA280097"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA248033"],"award-info":[{"award-number":["R01CA248033"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/bs.ircmb.2025.08.001","type":"book-chapter","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T11:15:10Z","timestamp":1756120510000},"page":"1-21","source":"Crossref","is-referenced-by-count":1,"title":["\u03b3\u03b4 T cells in prostate cancer"],"prefix":"10.1016","member":"78","reference":[{"key":"10.1016\/bs.ircmb.2025.08.001_bib1","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/eji.202149186","article-title":"Type I interferon supports \u03b3\u03b4 T-cell homeostasis and immunity through direct and indirect receptor signaling in mice","volume":"51","author":"Agerholm","year":"2021","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib2","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1002\/ijc.28217","article-title":"Human V\u03b32V\u03b42 t cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors","volume":"133","author":"Aggarwal","year":"2013","journal-title":"International Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/35081115","article-title":"Structure of a human \u03b3\u03b4 T-cell antigen receptor","volume":"411","author":"Allison","year":"2001","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib4","unstructured":"American Cancer Society. (2024). Key statistics for prostate cancer | prostate cancer facts. Available at: https:\/\/www.cancer.org\/cancer\/types\/prostate-cancer\/about\/key-statistics.html (Accessed 11 August 2024)."},{"key":"10.1016\/bs.ircmb.2025.08.001_bib5","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/s43018-024-00798-x","article-title":"\u03b3\u03b4 t cells as critical anti-tumor immune effectors","volume":"5","author":"Arias-Badia","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib6","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/322179a0","article-title":"A functional T3 molecule associated with a novel heterodimer on the surface of immature human thymocytes","volume":"322","author":"Bank","year":"1986","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ddstr.2006.02.001","article-title":"Phosphoantigens and aminobisphosphonates: New leads targeting \u03b3\u03b4 t lymphocytes for cancer immunotherapy","volume":"3","author":"Belmant","year":"2006","journal-title":"Drug Discovery Today. Therapeutic Strategies"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199602223340802","article-title":"Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma. Myeloma aredia study group","volume":"334","author":"Berenson","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib9","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1006\/abbi.1999.1502","article-title":"Alendronate is a specific, nanomolar inhibitor of farnesyl diphosphate synthase","volume":"373","author":"Bergstrom","year":"2000","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3389\/fimmu.2019.00569","article-title":"Histone deacetylase inhibitor modulates NKG2D receptor expression and memory phenotype of human Gamma\/Delta t cells upon interaction with tumor cells","volume":"10","author":"Bhat","year":"2019","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib11","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.7973709","article-title":"Modulation of epithelial cell growth by intraepithelial gamma delta t cells","volume":"266","author":"Boismenu","year":"1994","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib12","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/nri2781","article-title":"\u03b3\u03b4 t cell effector functions: A blend of innate programming and acquired plasticity","volume":"10","author":"Bonneville","year":"2010","journal-title":"Nature Reviews. Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/325683a0","article-title":"A T-cell receptor gamma\/CD3 complex found on cloned functional lymphocytes","volume":"325","author":"Borst","year":"1987","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib14","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1126\/science.1110267","article-title":"Professional antigen-presentation function by human \u03b3\u03b4 t cells","volume":"309","author":"Brandes","year":"2005","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/322145a0","article-title":"Identification of a putative second T-cell receptor","volume":"322","author":"Brenner","year":"1986","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib16","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ymthe.2017.12.001","article-title":"Chimeric antigen receptor-engineered human gamma delta t cells: Enhanced cytotoxicity with retention of cross presentation","volume":"26","author":"Capsomidis","year":"2018","journal-title":"Molecular therapy : The Journal of the American Society of Gene Therapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib17","doi-asserted-by":"crossref","first-page":"5271","DOI":"10.2147\/OTT.S107771","article-title":"Expression and prognostic significance of unique ULBPs in pancreatic cancer","volume":"9","author":"Chen","year":"2016","journal-title":"Onco Targets and Therapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108597","article-title":"Cancer stemness meets immunity: From mechanism to therapy","volume":"34","author":"Chen","year":"2021","journal-title":"Cell Reports"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib19","doi-asserted-by":"crossref","first-page":"1011081","DOI":"10.3389\/fonc.2022.1011081","article-title":"Intracellular radar: Understanding \u03b3\u03b4 t cell immune surveillance and implications for clinical strategies in oncology","volume":"12","author":"Cherry","year":"2022","journal-title":"Frontiers in Oncology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib20","doi-asserted-by":"crossref","first-page":"2138152","DOI":"10.1080\/2162402X.2022.2138152","article-title":"Human allogenic \u03b3\u03b4 t cells kill patient-derived glioblastoma cells expressing high levels of DNAM-1 ligands","volume":"11","author":"Choi","year":"2022","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib21","first-page":"13","article-title":"Prostate tumor microenvironment alters immune cells and prevents long-term survival in an orthotopic mouse model following flt3-ligand\/CD40-ligand immunotherapy","volume":"27","author":"Ciavarra","year":"2004","journal-title":"Journal of Immunotherapy (Hagerstown, Md)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib22","unstructured":"ClinicalTrials.gov. (2024). A phase I clinical trial of an infusion of autologous gamma delta T cells genetically engineered with a chimeric receptor to target the prostate stem cell antigen in patients with metastatic castration resistant prostate cancer. Available at: https:\/\/clinicaltrials.gov\/study\/NCT06193486 (Accessed 4 January 2025)."},{"key":"10.1016\/bs.ircmb.2025.08.001_bib23","unstructured":"ClinicalTrials.gov. (2019). A phase I dose-escalation trial to evaluate haploidentical \/ allogeneic natural killer group 2D ligand (NKG2DL)-targeting chimeric antigen receptor-grafted gamma delta (\u03b3\u03b4) T cells (CTM-N2D) in subjects with relapsed or refractory solid tumour. Available at: https:\/\/clinicaltrials.gov\/study\/NCT04107142 (Accessed 4 January 2025)."},{"key":"10.1016\/bs.ircmb.2025.08.001_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellimm.2020.104217","article-title":"Human and murine memory \u03b3\u03b4 t cells: Evidence for acquired immune memory in bacterial and viral infections and autoimmunity","volume":"357","author":"Comeau","year":"2020","journal-title":"Cellular Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1126\/science.8146660","article-title":"Stimulation of human gamma delta t cells by nonpeptidic mycobacterial ligands","volume":"264","author":"Constant","year":"1994","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib26","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1182\/blood-2011-02-339135","article-title":"Differentiation of human peripheral blood V\u03b41+ t cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells","volume":"118","author":"Correia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib27","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22892","article-title":"Tumor cell recognition by \u03b3\u03b4 t lymphocytes: T-cell receptor vs. Nk-cell receptors","volume":"2","author":"Correia","year":"2013","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2023-007955","article-title":"Therapeutic avenues for \u03b3\u03b4 t cells in cancer","volume":"11","author":"Costa","year":"2023","journal-title":"Journal of Immunotherapy Cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib29","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1074-7613(01)00168-6","article-title":"MICA engagement by human Vgamma2Vdelta2 t cells enhances their antigen-dependent effector function","volume":"15","author":"Das","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib30","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1182\/blood-2003-05-1655","article-title":"Induction of gammadelta T-lymphocyte effector functions by bisphosphonate zoledronic acid in cancer patients in vivo","volume":"102","author":"Dieli","year":"2003","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib31","doi-asserted-by":"crossref","first-page":"7450","DOI":"10.1158\/0008-5472.CAN-07-0199","article-title":"Targeting human \u03b3\u03b4 t cells with zoledronate and Interleukin-2 for immunotherapy of Hormone-Refractory prostate cancer","volume":"67","author":"Dieli","year":"2007","journal-title":"Cancer Research"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib32","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/BF01225275","article-title":"Heat-shock proteins and the gamma delta t cell response in virus infections: implications for autoimmunity","volume":"13","author":"Doherty","year":"1991","journal-title":"Springer Seminars in Immunopathology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib33","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41591-024-02979-8","article-title":"PSCA-CAR t cell therapy in metastatic castration-resistant prostate cancer: A phase 1 trial","volume":"30","author":"Dorff","year":"2024","journal-title":"Nature Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.dci.2024.105250","article-title":"Characterization of a novel chicken \u03b3\u03b4 TCR-specific marker","volume":"161","author":"Drexel","year":"2024","journal-title":"Developmental and Comparative Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib35","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/S0014-5793(03)00483-6","article-title":"Microbial isoprenoid biosynthesis and human gammadelta t cell activation","volume":"544","author":"Eberl","year":"2003","journal-title":"FEBS Letters"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib36","doi-asserted-by":"crossref","first-page":"9287","DOI":"10.1073\/pnas.96.16.9287","article-title":"High expression of a specific T-cell receptor gamma transcript in epithelial cells of the prostate","volume":"96","author":"Essand","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib37","unstructured":"E.U. Clinical Trials Register. (2021). Clinical trials for 2021-001789-39. Available at: https:\/\/www.clinicaltrialsregister.eu\/ctr-search\/search?query=+2021-001789-39 (Accessed 4 January 2025)."},{"key":"10.1016\/bs.ircmb.2025.08.001_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1080\/14656566.2019.1574754","article-title":"Zoledronic acid for the treatment of prostate cancer","volume":"20","author":"Finianos","year":"2019","journal-title":"Expert Opinion on Pharmacotherapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib39","doi-asserted-by":"crossref","DOI":"10.4161\/onci.27572","article-title":"\u03b3\u03b4 t cells for cancer immunotherapy: A systematic review of clinical trials","volume":"3","author":"Fisher","year":"2014","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib40","doi-asserted-by":"crossref","first-page":"eadf0108","DOI":"10.1126\/sciadv.adf0108","article-title":"\u03b3\u03b4-Enriched CAR-T cell therapy for bone metastatic castrate-resistant prostate cancer","volume":"9","author":"Frieling","year":"2023","journal-title":"Science Advances"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1084\/jem.20030584","article-title":"\u03b3\u03b4 t cells provide an early source of interferon \u03b3 in tumor immunity","volume":"198","author":"Gao","year":"2003","journal-title":"The Journal of Experimental Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib42","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/bjc.2017.79","article-title":"MHC class I chain-related protein a and b (MICA and MICB) are predominantly expressed intracellularly in tumour and normal tissue","volume":"116","author":"Ghadially","year":"2017","journal-title":"British Journal of Cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib43","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.eururo.2019.08.014","article-title":"Challenges and prospects of chimeric antigen receptor T-cell therapy for metastatic prostate cancer","volume":"77","author":"Gorchakov","year":"2020","journal-title":"European Urology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib44","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202052234","article-title":"MicroRNA\u2010181a restricts human \u03b3\u03b4 t cell differentiation by targeting Map3k2 and Notch2","volume":"23","author":"Gordino","year":"2022","journal-title":"EMBO Reports"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib45","doi-asserted-by":"crossref","first-page":"6879","DOI":"10.1073\/pnas.96.12.6879","article-title":"Broad tumor-associated expression and recognition by tumor-derived gamma delta t cells of MICA and MICB","volume":"96","author":"Groh","year":"1999","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib46","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1126\/science.279.5357.1737","article-title":"Recognition of stress-induced MHC molecules by intestinal epithelial gammadelta t cells","volume":"279","author":"Groh","year":"1998","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib47","first-page":"E7311","article-title":"Phosphoantigen-induced conformational change of butyrophilin 3A1 (BTN3A1) and its implication on V\u03b39V\u03b42 t cell activation","volume":"114","author":"Gu","year":"2017","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib48","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/sj.onc.1203426","article-title":"Prostate stem cell antigen (PSCA) expression increases with high gleason score, advanced stage and bone metastasis in prostate cancer","volume":"19","author":"Gu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib49","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1126\/science.1828619","article-title":"Recognition of self antigens by skin-derived t cells with invariant gamma delta antigen receptors","volume":"252","author":"Havran","year":"1991","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib50","doi-asserted-by":"crossref","first-page":"eabq7248","DOI":"10.1126\/science.abq7248","article-title":"Cancer immunotherapy by \u03b3\u03b4 t cells","volume":"386","author":"Hayday","year":"2024","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib51","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0092-8674(85)90140-0","article-title":"Structure, organization, and somatic rearrangement of t cell gamma genes","volume":"40","author":"Hayday","year":"1985","journal-title":"Cell"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib52","doi-asserted-by":"crossref","first-page":"2451068","DOI":"10.1002\/eji.202451068","article-title":"Phosphoantigen recognition by V\u03b39V\u03b42 t cells","volume":"54","author":"Herrmann","year":"2024","journal-title":"European Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib53","doi-asserted-by":"crossref","first-page":"800","DOI":"10.3389\/fimmu.2018.00800","article-title":"Improving the efficiency of V\u03b39V\u03b42 T-Cell immunotherapy in cancer","volume":"9","author":"Hoeres","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib54","article-title":"V\u03b39V\u03b42 t cells concurrently kill cancer cells and Cross-Present tumor antigens","volume":"12","author":"Holmen","year":"2021","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib55","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1056\/NEJM199612123352401","article-title":"Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. Protocol 19 aredia breast cancer study group","volume":"335","author":"Hortobagyi","year":"1996","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01653-8","article-title":"\u03b3\u03b4 t cells: Origin and fate, subsets, diseases and immunotherapy","volume":"8","author":"Hu","year":"2023","journal-title":"Signal Transduction and Targeted Therapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00258","article-title":"Roles of IFN-\u03b3 and \u03b3\u03b4 t cells in protective immunity against blood-stage malaria","volume":"4","author":"Inoue","year":"2013","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib58","doi-asserted-by":"crossref","first-page":"2870","DOI":"10.1182\/bloodadvances.2019032409","article-title":"Identification of a tumor-specific allo-HLA-restricted \u03b3\u03b4TCR","volume":"3","author":"Kierkels","year":"2019","journal-title":"Blood Advances"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib59","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1111\/j.1742-1241.2011.02799.x","article-title":"Characterising the castration-resistant prostate cancer population: A systematic review","volume":"65","author":"Kirby","year":"2011","journal-title":"International Journal of Clinical Practice"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib60","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3390\/cells11010020","article-title":"Myeloid-Derived suppressor cells in prostate cancer: Present knowledge and future perspectives","volume":"11","author":"Koinis","year":"2021","journal-title":"Cells"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib61","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1080\/14653240802419328","article-title":"Zoledronate facilitates large-scale ex vivo expansion of functional \u03b3\u03b4 t cells from cancer patients for use in adoptive immunotherapy*","volume":"10","author":"Kondo","year":"2008","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib62","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJM199903043400914","article-title":"Gamma\/delta T-cell stimulation by pamidronate","volume":"340","author":"Kunzmann","year":"1999","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib63","doi-asserted-by":"crossref","first-page":"19282","DOI":"10.1074\/jbc.M910487199","article-title":"Tumor necrosis Factor-\u03b1 production is differently regulated in \u03b3\u03b4 and \u03b1\u03b2 human t lymphocytes *","volume":"275","author":"Lafont","year":"2000","journal-title":"The Journal of Biological Chemistry"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib64","doi-asserted-by":"crossref","first-page":"6673","DOI":"10.4049\/jimmunol.1300434","article-title":"Protective role of the inflammatory CCR2\/CCL2 chemokine pathway through recruitment of type 1 cytotoxic \u03b3\u03b4 t lymphocytes to tumor beds","volume":"190","author":"Lan\u00e7a","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib65","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13039-024-00680-6","article-title":"Loss of heterozygosity impacts MHC expression on the immune microenvironment in CDK12-mutated prostate cancer","volume":"17","author":"Lautert-Dutra","year":"2024","journal-title":"Molecular Cytogenetics"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib66","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/316464a0","article-title":"Two tandemly organized human genes encoding the T-cell gamma constant-region sequences show multiple rearrangement in different T-cell types","volume":"316","author":"Lefranc","year":"1985","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib67","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/35172","article-title":"Structure of the V\u03b4 domain of a human \u03b3\u03b4 T-cell antigen receptor","volume":"391","author":"Li","year":"1998","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib68","doi-asserted-by":"crossref","first-page":"7131","DOI":"10.4049\/jimmunol.181.10.7131","article-title":"TNF-\u03b1 is a positive regulatory factor for human V\u03b32V\u03b42 t cells","volume":"181","author":"Li","year":"2008","journal-title":"Journal of immunology (Baltimore, Md 1950)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib69","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1186\/s12967-023-04743-x","article-title":"Silencing HOXC13 exerts anti-prostate cancer effects by inducing DNA damage and activating cGAS\/STING\/IRF3 pathway","volume":"21","author":"Li","year":"2023","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117252","article-title":"Antigen escape in CAR-T cell therapy: Mechanisms and overcoming strategies","volume":"178","author":"Lin","year":"2024","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib71","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/imm.13542","article-title":"Distinct activities of V\u03b41+ T-cells upon different cytomegalovirus reactivation status after haematopoietic transplantation","volume":"167","author":"Liu","year":"2022","journal-title":"Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib72","article-title":"Ex vivo expanded human V\u03bb9v\u03b42+ \u039b\u03b4-t cells mediate innate antitumor activity against human prostate cancer cells in vitro","author":"Liu","year":"2005","journal-title":"The Journal of Urology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023348","article-title":"Human ovarian tumor cells escape \u03b3\u03b4 t cell recognition partly by down regulating surface expression of MICA and limiting cell cycle related molecules","volume":"6","author":"Lu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib74","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1126\/science.2528206","article-title":"Structure and specificity of a class II MHC alloreactive gamma delta t cell receptor heterodimer","volume":"245","author":"Matis","year":"1989","journal-title":"Science (New York, N. Y.)"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib75","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1200\/JCO.2022.40.6_suppl.094","article-title":"Safety and early efficacy results from a phase 1, multicenter trial of PSMA-targeted armored CAR t cells in patients with advanced mCRPC","volume":"40","author":"McKean","year":"2022","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib76","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/s41571-022-00722-1","article-title":"The emerging roles of \u03b3\u03b4 t cells in cancer immunotherapy","volume":"20","author":"Mensurado","year":"2023","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib77","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2010.04167.x","article-title":"In vivo manipulation of Vgamma9Vdelta2 t cells with zoledronate and low-dose interleukin-2 for immunotherapy of advanced breast cancer patients","volume":"161","author":"Meraviglia","year":"2010","journal-title":"Clinical and Experimental Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib78","doi-asserted-by":"crossref","first-page":"5481","DOI":"10.21873\/anticanres.14559","article-title":"Sphere-derived prostate cancer stem cells are resistant to \u03b3\u03b4 t cell cytotoxicity","volume":"40","author":"Miyashita","year":"2020","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s002810000042","article-title":"Antigen recognition by human gamma delta t cells: pattern recognition by the adaptive immune system","volume":"22","author":"Morita","year":"2000","journal-title":"Springer Seminars in Immunopathology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib80","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/j.jaci.2023.07.015","article-title":"IFN-\u03b3-dependent interactions between tissue-intrinsic \u03b3\u03b4 t cells and tissue-infiltrating CD8 t cells limit allergic contact dermatitis","volume":"152","author":"Mu\u00f1oz-Ruiz","year":"2023","journal-title":"The Journal of Allergy and Clinical Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib81","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/316549a0","article-title":"Human gamma-chain genes are rearranged in leukaemic t cells and map to the short arm of chromosome 7","volume":"316","author":"Murre","year":"1985","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib82","doi-asserted-by":"crossref","first-page":"1989789","DOI":"10.1080\/2162402X.2021.1989789","article-title":"PD-1 checkpoint blockade enhances adoptive immunotherapy by human V\u03b32V\u03b42 t cells against human prostate cancer","volume":"10","author":"Nada","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s40425-017-0209-6","article-title":"Enhancing adoptive cancer immunotherapy with V\u03b32V\u03b42 t cells through pulse zoledronate stimulation","volume":"5","author":"Nada","year":"2017","journal-title":"Journal for Immuno Therapy of Cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib84","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s11357-023-00806-5","article-title":"Lifelong exercise training promotes the remodelling of the immune system and prostate signalome in a rat model of prostate carcinogenesis","volume":"46","author":"Nascimento-Gon\u00e7alves","year":"2024","journal-title":"GeroScience"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib85","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1007\/s00277-023-05583-x","article-title":"Lymphocyte subsets and soluble forms of MIC-A and MIC-B are prognostic factors in non-Hodgkin lymphoma patients","volume":"103","author":"Olivas-Bejarano","year":"2024","journal-title":"Annals of Hematology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib86","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcyt.2021.02.003","article-title":"The capacity of CD4+ V\u03b39V\u03b42 t cells to kill cancer cells correlates with co-expression of CD56","volume":"23","author":"Olofsson","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib87","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.3389\/fimmu.2020.01839","article-title":"Perforins expression by cutaneous gamma delta t cells","volume":"11","author":"O\u2019Neill","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib88","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s12276-021-00576-0","article-title":"Function of \u03b3\u03b4 t cells in tumor immunology and their application to cancer therapy","volume":"53","author":"Park","year":"2021","journal-title":"Experimental & Molecular Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib89","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1189\/jlb.3RU0914-443R","article-title":"Role of gamma-delta (\u03b3\u03b4) t cells in autoimmunity","volume":"97","author":"Paul","year":"2015","journal-title":"Journal of Leukocyte Biology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib90","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.immuni.2007.05.020","article-title":"Tumor-infiltrating gammadelta t cells suppress t and dendritic cell function via mechanisms controlled by a unique toll-like receptor signaling pathway","volume":"27","author":"Peng","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib91","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.3389\/fimmu.2020.01347","article-title":"Gamma-Delta CAR-T cells show CAR-Directed and independent activity against leukemia","volume":"11","author":"Rozenbaum","year":"2020","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib92","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.01271","article-title":"Myeloid-Derived suppressor cells specifically suppress IFN-\u03b3 production and antitumor cytotoxic activity of V\u03b42 t cells","volume":"9","author":"Sacchi","year":"2018","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib93","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/309757a0","article-title":"Complete primary structure of a heterodimeric T-cell receptor deduced from cDNA sequences","volume":"309","author":"Saito","year":"1984","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib94","first-page":"22","article-title":"The safety and efficacy of CAR-T cells in the treatment of prostate cancer: Review","volume":"27","author":"Saleh","year":"2022","journal-title":"Biomark. Biochem. Indic. Expo. Response Susceptibility Chem"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib95","doi-asserted-by":"crossref","first-page":"6035","DOI":"10.1038\/s41467-023-41634-7","article-title":"Modulation of lytic molecules restrain serial killing in \u03b3\u03b4 t lymphocytes","volume":"14","author":"Sandoz","year":"2023","journal-title":"Nature Communications"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib96","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1093\/annonc\/mdg401","article-title":"The antineoplastic role of bisphosphonates: From basic research to clinical evidence","volume":"14","author":"Santini","year":"2003","journal-title":"Annals of Oncology: Official Journal of the European Society for Medical Oncology \/ ESMO"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib97","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.4049\/jimmunol.1300255","article-title":"Repeated systemic administrations of both aminobisphosphonates and human V\u03b39V\u03b42 t cells efficiently control tumor development in vivo","volume":"191","author":"Santolaria","year":"2013","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib98","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.21873\/anticanres.15829","article-title":"Synergistic benefit of adoptive t cells in combination with chemoradiotherapy against metastatic prostate cancer cells","volume":"42","author":"Shen","year":"2022","journal-title":"Anticancer Research"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib99","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00262-012-1353-y","article-title":"Extensive expansion of primary human gamma delta t cells generates cytotoxic effector memory cells that can be labeled with feraheme for cellular MRI","volume":"62","author":"Siegers","year":"2013","journal-title":"Cancer Immunology, Immunotherapy CII"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib100","doi-asserted-by":"crossref","first-page":"543","DOI":"10.4049\/jimmunol.2400114","article-title":"The evolving portrait of \u03b3\u03b4 TCR recognition determinants","volume":"213","author":"Sok","year":"2024","journal-title":"Journal of Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib101","article-title":"Targeting cytokine signals to enhance \u03b3\u03b4T Cell-Based cancer immunotherapy","volume":"13","author":"Song","year":"2022","journal-title":"Frontiers in Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib102","doi-asserted-by":"crossref","DOI":"10.1007\/s00262-007-0279-2","article-title":"Chemotherapy and zoledronate sensitize solid tumour cells to Vgamma9Vdelta2 t cell cytotoxicity","volume":"56","author":"Mattarollo","year":"2007","journal-title":"Cancer Immunology and Immunotherapy CII"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib103","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jcyt.2020.09.010","article-title":"Bortezomib enhances cytotoxicity of ex vivo expanded gamma delta (\u03b3\u03b4) t cells against AML and T-ALL","volume":"23","author":"Story","year":"2021","journal-title":"Cytotherapy"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib104","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1038\/s41590-024-01855-4","article-title":"Perinatal thymic-derived CD8\u03b1\u03b2-expressing \u03b3\u03b4 t cells are innate IFN-\u03b3 producers that expand in IL-7R\u2013STAT5B-driven neoplasms","volume":"25","author":"Sumaria","year":"2024","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib105","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0304-3835(93)90125-S","article-title":"Changes of gamma\/delta t cells in blood after radiation therapy for prostatic cancer","volume":"72","author":"Svensson","year":"1993","journal-title":"Cancer Letters"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib106","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/375155a0","article-title":"Natural and synthetic non-peptide antigens recognized by human gamma delta t cells","volume":"375","author":"Tanaka","year":"1995","journal-title":"Nature"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib107","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/cas.13491","article-title":"Expansion of human \u03b3\u03b4 t cells for adoptive immunotherapy using a bisphosphonate prodrug","volume":"109","author":"Tanaka","year":"2018","journal-title":"Cancer Science"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib108","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1200\/JCO.1999.17.3.846","article-title":"Pamidronate reduces skeletal morbidity in women with advanced breast cancer and lytic bone lesions: A randomized, placebo-controlled trial. Protocol 18 aredia breast cancer study group","volume":"17","author":"Theriault","year":"1999","journal-title":"Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib109","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1284723","article-title":"Assessment of tumor-infiltrating TCRV\u03b39V\u03b42 \u03b3\u03b4 lymphocyte abundance by deconvolution of human cancers microarrays","volume":"6","author":"Tosolini","year":"2017","journal-title":"Oncoimmunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib110","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.pharmthera.2015.11.008","article-title":"Bisphosphonates for cancer treatment: Mechanisms of action and lessons from clinical trials","volume":"158","author":"Van Acker","year":"2016","journal-title":"Pharmacology & Therapeutics"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib111","doi-asserted-by":"crossref","first-page":"91","DOI":"10.4111\/icu.2019.60.2.91","article-title":"Characterization of human infiltrating and circulating gamma-delta t cells in prostate cancer","volume":"60","author":"Vella","year":"2019","journal-title":"Investigative and Clinical Urology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib112","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1182\/blood-2021-149095","article-title":"Induced pluripotent stem cell-derived gamma delta CAR-T cells for cancer immunotherapy","volume":"138","author":"Wallet","year":"2021","journal-title":"Blood"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib113","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41551-020-0592-z","article-title":"Classification of T-cell activation via autofluorescence lifetime imaging","volume":"5","author":"Walsh","year":"2021","journal-title":"Nature Biomedical Engineering"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib114","first-page":"17545","article-title":"The role of NKG2D and its ligands in autoimmune diseases: New targets for immunotherapy","volume":"24","author":"Wei","year":"2023","journal-title":"International Journal of Cell Science & Molecular Biology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s12967-024-05132-8","article-title":"Double-negative t cells ameliorate psoriasis by selectively inhibiting IL-17A-producing \u03b3\u03b4low t cells","volume":"22","author":"Wei","year":"2024","journal-title":"Journal of Translational Medicine"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib116","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/s41590-018-0304-y","article-title":"\u03b3\u03b4 TCR ligands: The quest to solve a 500-million-year-old mystery","volume":"20","author":"Willcox","year":"2019","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib117","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/ni.2394","article-title":"Cytomegalovirus and tumor stress surveillance by binding of a human \u03b3\u03b4 t cell antigen receptor to endothelial protein c receptor","volume":"13","author":"Willcox","year":"2012","journal-title":"Nature Immunology"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib118","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1172\/JCI200422206","article-title":"Prevalent expression of the immunostimulatory MHC class I chain-related molecule is counteracted by shedding in prostate cancer","volume":"114","author":"Wu","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib119","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1038\/s43018-022-00376-z","article-title":"A local human V\u03b41 t cell population is associated with survival in nonsmall-cell lung cancer","volume":"3","author":"Wu","year":"2022","journal-title":"Nature cancer"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib120","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1073\/pnas.1015433108","article-title":"Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA","volume":"108","author":"Xu","year":"2011","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib121","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12964-024-01711-w","article-title":"Mechanisms, combination therapy, and biomarkers in cancer immunotherapy resistance","volume":"22","author":"Yang","year":"2024","journal-title":"Cell Communication Signal CCS"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib122","article-title":"Recent advances in heat shock proteins in cancer diagnosis, prognosis, metabolism and treatment","volume":"142","author":"Yang","year":"2021","journal-title":"Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib123","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.3390\/cancers16173098","article-title":"Developmental therapeutics in metastatic prostate cancer: new targets and new strategies","volume":"16","author":"Zhang","year":"2024","journal-title":"Cancers"},{"key":"10.1016\/bs.ircmb.2025.08.001_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156108","article-title":"The way of interaction between V\u03b39V\u03b42 t cells and tumor cells","volume":"162","author":"Zhang","year":"2023","journal-title":"Cytokine"}],"container-title":["International Review of Cell and Molecular Biology","\u03b3\u03b4 \u22a4 Cells in Health and Disease - Part A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1937644825001078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T10:03:46Z","timestamp":1760695426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1937644825001078"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"ISBN":["9780443415845"],"references-count":124,"URL":"https:\/\/doi.org\/10.1016\/bs.ircmb.2025.08.001","relation":{},"ISSN":["1937-6448"],"issn-type":[{"value":"1937-6448","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]}}}